<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38663887</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4439</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>24</Day></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Long COVID exhibits clinically distinct phenotypes at 3-6 months post-SARS-CoV-2 infection: results from the P4O2 consortium.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e001907</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2023-001907</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Four months after SARS-CoV-2 infection, 22%-50% of COVID-19 patients still experience complaints. Long COVID is a heterogeneous disease and finding subtypes could aid in optimising and developing treatment for the individual patient.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data were collected from 95 patients in the P4O2 COVID-19 cohort at 3-6 months after infection. Unsupervised hierarchical clustering was performed on patient characteristics, characteristics from acute SARS-CoV-2 infection, long COVID symptom data, lung function and questionnaires describing the impact and severity of long COVID. To assess robustness, partitioning around medoids was used as alternative clustering.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three distinct clusters of patients with long COVID were revealed. Cluster 1 (44%) represented predominantly female patients (93%) with pre-existing asthma and suffered from a median of four symptom categories, including fatigue and respiratory and neurological symptoms. They showed a milder SARS-CoV-2 infection. Cluster 2 (38%) consisted of predominantly male patients (83%) with cardiovascular disease (CVD) and suffered from a median of three symptom categories, most commonly respiratory and neurological symptoms. This cluster also showed a significantly lower forced expiratory volume within 1 s and diffusion capacity of the lung for carbon monoxide. Cluster 3 (18%) was predominantly male (88%) with pre-existing CVD and diabetes. This cluster showed the mildest long COVID, and suffered from symptoms in a median of one symptom category.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Long COVID patients can be clustered into three distinct phenotypes based on their clinical presentation and easily obtainable information. These clusters show distinction in patient characteristics, lung function, long COVID severity and acute SARS-CoV-2 infection severity. This clustering can help in selecting the most beneficial monitoring and/or treatment strategies for patients suffering from long COVID. Follow-up research is needed to reveal the underlying molecular mechanisms implicated in the different phenotypes and determine the efficacy of treatment.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blankestijn</LastName><ForeName>Jelle M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0009-0006-2047-0888</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands j.m.blankestijn@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel-Aziz</LastName><ForeName>Mahmoud I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Assiut University Faculty of Pharmacy, Assiut, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baalbaki</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazdar</LastName><ForeName>Somayeh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beekers</LastName><ForeName>In&#xe9;s</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>ORTEC, Zoetermeer, Zuid-Holland, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beijers</LastName><ForeName>Rosanne J H C G</ForeName><Initials>RJHCG</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universiteit Maastricht School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloemsma</LastName><ForeName>Lizan D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornelissen</LastName><ForeName>Merel E B</ForeName><Initials>MEB</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gach</LastName><ForeName>Debbie</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universiteit Maastricht School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houweling</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environmental Epidemiology, Utrecht University Institute for Risk Assessment Sciences, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holverda</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Longfonds, Amersfoort, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>John J L</ForeName><Initials>JJL</Initials><AffiliationInfo><Affiliation>ORTEC, Zoetermeer, Zuid-Holland, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonker</LastName><ForeName>Rene&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Lee</LastName><ForeName>Ivo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Spaarne Gasthuis, Haarlem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linders</LastName><ForeName>Paulien M A</ForeName><Initials>PMA</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed Hoesein</LastName><ForeName>Firdaus A A</ForeName><Initials>FAA</Initials><AffiliationInfo><Affiliation>Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noij</LastName><ForeName>Lieke C E</ForeName><Initials>LCE</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nossent</LastName><ForeName>Esther J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Pol</LastName><ForeName>Marianne A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaminee</LastName><ForeName>Daphne W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schols</LastName><ForeName>Annemie M W J</ForeName><Initials>AMWJ</Initials><AffiliationInfo><Affiliation>Universiteit Maastricht School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuurman</LastName><ForeName>Lisanne T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universiteit Maastricht School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sondermeijer</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Spaarne Gasthuis, Haarlem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geelhoed</LastName><ForeName>J J Miranda</ForeName><Initials>JJM</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Bergh</LastName><ForeName>Joop P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weersink</LastName><ForeName>Els J M</ForeName><Initials>EJM</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Wit-van Wijck</LastName><ForeName>Yolanda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maitland-van der Zee</LastName><ForeName>Anke H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Respiratory Medicine, Emma Childrens' Hospital UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>P4O2 consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005541" MajorTopicYN="N">Forced Expiratory Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword></KeywordList><CoiStatement>Competing interests: MIA-A was funded by a full PhD scholarship from the Ministry of Higher Education of the Arab Republic of Egypt during the conduct of the study and received a grant from Stichting Astma Bestrijding. AHM received money paid to the institution from the ZonMW grant long COVID, the Stichting TAAI research grant, the EUROSTARS research grant COPDetect, an unrestricted research grant from Boehringer Ingelheim, an unrestricted research grant from the Vertex Innovation Award, a Dutch Lung Foundation grant, a Stichting Asthma Bestrijding grant and the Innovative Medicine Initiative (IMI) 3TR research grant. AHM received consulting fees from Astra Zeneca and Boehringer Ingelheim and received a honorarium for a lecture from GSK. AHM is the (unpaid) chair of the DSMB SOS BPD study, an advisory board member of the CHAMP study, president of the federation of innovative drug research in the Netherlands (FIGON) and president of the European Association of systems medicine (EASYM).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>26</Day><Hour>0</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>26</Day><Hour>0</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>25</Day><Hour>20</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38663887</ArticleId><ArticleId IdType="pmc">PMC11043734</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2023-001907</ArticleId><ArticleId IdType="pii">11/1/e001907</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Orginazation . WHO Coronavirus (COVID-19) dashboard. 2023. Available: https://covid19.who.int/
</Citation></Reference><Reference><Citation>Jones EAK, Mitra AK, Bhuiyan AR. Impact of COVID-19 on mental health in adolescents: a systematic review. Int J Environ Res Public Health 2021;18:2470. 10.3390/ijerph18052470</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052470</ArticleId><ArticleId IdType="pmc">PMC7967607</ArticleId><ArticleId IdType="pubmed">33802278</ArticleId></ArticleIdList></Reference><Reference><Citation>Delardas O, Kechagias KS, Pontikos PN, et al. . Socio-economic impacts and challenges of the Coronavirus pandemic (COVID-19): an updated review. Sustainability 2022;14:9699. 10.3390/su14159699</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/su14159699</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilamakuri R, Agarwal S. COVID-19: characteristics and therapeutics. Cells 2021;10:206. 10.3390/cells10020206</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020206</ArticleId><ArticleId IdType="pmc">PMC7909801</ArticleId><ArticleId IdType="pubmed">33494237</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, et al. . The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine 2023;55:101762. 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. . Characterising long COVID: a living systematic review. BMJ Glob Health 2021;6:e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta EM, Spallone A, Rodriguez-Barradas MC, et al. . Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis 2020;7:ofaa509. 10.1093/ofid/ofaa509</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa509</ArticleId><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, et al. . Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis 2022;9:ofac060. 10.1093/ofid/ofac060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese JT, Blau H, Casiraghi E, et al. . Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine 2023;87:104413. 10.1016/j.ebiom.2022.104413</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104413</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Florencio LL, et al. . Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical Co-morbidities in previously hospitalized COVID-19 survivors. Infection 2023;51:61&#x2013;9. 10.1007/s15010-022-01822-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Badier N, Zhang L, et al. . Long COVID classification: findings from a clustering analysis in the Predi-COVID cohort study. Int J Environ Res Public Health 2022;19:16018. 10.3390/ijerph192316018</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316018</ArticleId><ArticleId IdType="pmc">PMC9740149</ArticleId><ArticleId IdType="pubmed">36498091</ArticleId></ArticleIdList></Reference><Reference><Citation>Baalbaki N, Blankestijn JM, Abdel-Aziz MI, et al. . Precision medicine for more oxygen (P4O2)-Study design and first results of the long COVID-19 extension. J Pers Med 2023;13:1060. 10.3390/jpm13071060</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm13071060</ArticleId><ArticleId IdType="pmc">PMC10381397</ArticleId><ArticleId IdType="pubmed">37511673</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, LaRocca NG, Muir-Nash J, et al. . The fatigue severity scale. application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121&#x2013;3. 10.1001/archneur.1989.00520460115022</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays RD, Bjorner JB, Revicki DA, et al. . Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res 2009;18:873&#x2013;80. 10.1007/s11136-009-9496-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-009-9496-9</ArticleId><ArticleId IdType="pmc">PMC2724630</ArticleId><ArticleId IdType="pubmed">19543809</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins A, Bovin MJ, Smolenski DJ, et al. . The primary care PTSD screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sample. J Gen Intern Med 2016;31:1206&#x2013;11. 10.1007/s11606-016-3703-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-016-3703-5</ArticleId><ArticleId IdType="pmc">PMC5023594</ArticleId><ArticleId IdType="pubmed">27170304</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, et al. . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727&#x2013;36. 10.1007/s11136-011-9903-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>van Heugten C, Rasquin S, Winkens I, et al. . Checklist for cognitive and emotional consequences following stroke (CLCE-24): development, usability and quality of the self-report version. Clin Neurol Neurosurg 2007;109:257&#x2013;62. 10.1016/j.clineuro.2006.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2006.10.002</ArticleId><ArticleId IdType="pubmed">17126480</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee CH, Priesterbach AR, van der Dussen L, et al. . Reproducibility of three self-report participation measures: the ICF measure of participation and activities Screener, the participation scale, and the Utrecht scale for evaluation of rehabilitation-participation. J Rehabil Med 2010;42:752&#x2013;7. 10.2340/16501977-0589</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-0589</ArticleId><ArticleId IdType="pubmed">20809057</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361&#x2013;70. 10.1111/j.1600-0447.1983.tb09716.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw 2011;45:1&#x2013;67. 10.18637/jss.v045.i03</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v045.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Maechler M, Rousseeuw P, Struyf A, et al. . cluster: cluster analysis basics and extensions. R package version 2.1.2. 2021.</Citation></Reference><Reference><Citation>R Core Team . R: A language and environment for statistical computing. 2013.</Citation></Reference><Reference><Citation>Wu C, Chen X, Cai Y, et al. . Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934&#x2013;43. 10.1001/jamainternmed.2020.0994</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Boerdam A, Knoops K. Bevolkingstrends: astma En COPD in Beeld. Centraal Bureau voor de Statistiek, 2016.</Citation></Reference><Reference><Citation>Agondi RC, Menechino N, Marinho AKBB, et al. . Worsening of asthma control after COVID-19. Front Med (Lausanne) 2022;9:882665. 10.3389/fmed.2022.882665</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.882665</ArticleId><ArticleId IdType="pmc">PMC9524244</ArticleId><ArticleId IdType="pubmed">36186769</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok WC, Tam TCC, Lam DCL, et al. . Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong. Respir Res 2023;24:53. 10.1186/s12931-023-02363-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-023-02363-z</ArticleId><ArticleId IdType="pmc">PMC9927038</ArticleId><ArticleId IdType="pubmed">36788605</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023;21:133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, Hirose M, Inoue Y, et al. . Relationship between changes in symptoms and antibody titers after a single vaccination in patients with long COVID. J Med Virol 2022;94:3416&#x2013;20. 10.1002/jmv.27689</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27689</ArticleId><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn S, Hoek A, Mutubuki EN, et al. . Lower prevalence of post-COVID-19 condition following Omicron SARS-CoV-2 infection. medRxiv 2023;2023:2023.04.05.23288157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11015416</ArticleId><ArticleId IdType="pubmed">38617937</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JL, Oviedo SA, Ali MK, et al. . The Bidirectional association between diabetes and long-COVID-19 - a systematic review. Diabetes Res Clin Pract 2023;195:110202. 10.1016/j.diabres.2022.110202</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2022.110202</ArticleId><ArticleId IdType="pmc">PMC9727969</ArticleId><ArticleId IdType="pubmed">36496030</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. . Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 2022;13:1957. 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, Moik F, Klok FA, et al. . Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration 2022;101:593&#x2013;601. 10.1159/000522118</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>